Company Comera Life Sciences Holdings, Inc.
Equities
CMRA
US20037C1080
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.028 USD | +0.90% | +23.35% | -49.09% |
30/01 | Comera Life Sciences Holdings, Inc. Announces Chief Executive Officer Changes | CI |
30/01 | Comera Life Sciences Holdings, Inc. Announces Changes to Its Board | CI |
Business Summary
Number of employees: 13
Sales per Business
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| - | - | 1 | 100.0 % | - |
Sales per region
USD in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 1 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Campbell
CEO | Chief Executive Officer | - | 13/22/13 |
Corporate Officer/Principal | - | 09/22/09 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stuart Randle
BRD | Director/Board Member | 64 | 19/22/19 |
James Sherblom
BRD | Director/Board Member | 68 | 01/21/01 |
Director/Board Member | 48 | 19/22/19 | |
Kirsten Flowers
BRD | Director/Board Member | 49 | 19/22/19 |
Edward Sullivan
BRD | Director/Board Member | - | 01/21/01 |
Dorothy Clarke
BRD | Director/Board Member | 59 | 13/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 30,737,796 | 9,077,561 ( 29.53 %) | 0 | 29.53 % |
Stock B | 0 | 4,305 | 0 | 0 |
Company contact information
Comera Life Sciences Holdings, Inc.
12 Gill Street Suite 4650
01801, Woburn
+
http://comeralifesciences.comSector
1st Jan change | Capi. | |
---|---|---|
-49.09% | 861K | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- CMRA Stock
- Company Comera Life Sciences Holdings, Inc.